Evidence map›Paper›PMID 31869347›Full record

ArticlePloS one2019

Determining the molecular drivers of species-specific interferon-stimulated gene product 15 interactions with nairovirus ovarian tumor domain proteases.

John V Dzimianski, Florine E M Scholte, Isabelle L Williams, Caroline Langley, Brendan T Freitas, Jessica R Spengler, Éric Bergeron, Scott D Pegan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

John V DzimianskiDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
Florine E M ScholteDivision of High Consequence Pathogens and Pathology, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-2110-3087
Isabelle L WilliamsDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
Caroline LangleyDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-0459-0568
Brendan T FreitasDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0001-5847-5904
Jessica R SpenglerDivision of High Consequence Pathogens and Pathology, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0002-5383-0513
Éric BergeronDivision of High Consequence Pathogens and Pathology, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-3398-8628
Scott D PeganDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-2958-5319
University of Georgia · USCenters for Disease Control and Prevention · US

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
Origin of the innate immunity suppression caused by nairovirus' protease activityR01AI109008 · NIAID · UNIVERSITY OF GEORGIA · PI PEGAN, SCOTT DUSAN · 2014 to 2018
$1.6M
NIAID NIH HHS R01 AI109008NIGMS NIH HHS P30 GM133893NIGMS NIH HHS P41 GM111244
6 · The paper itself

Abstract

Tick-borne nairoviruses (order Bunyavirales) encode an ovarian tumor domain protease (OTU) that suppresses the innate immune response by reversing the post-translational modification of proteins by ubiquitin (Ub) and interferon-stimulated gene product 15 (ISG15). Ub is highly conserved across eukaryotes, whereas ISG15 is only present in vertebrates and shows substantial sequence diversity. Prior attempts to address the effect of ISG15 diversity on viral protein-ISG15 interactions have focused on only a single species' ISG15 or a limited selection of nairovirus OTUs. To gain a more complete perspective of OTU-ISG15 interactions, we biochemically assessed the relative activities of 14 diverse nairovirus OTUs for 12 species' ISG15 and found that ISG15 activity is predominantly restricted to particular nairovirus lineages reflecting, in general, known virus-host associations. To uncover the underlying molecular factors driving OTUs affinity for ISG15, X-ray crystal structures of Kupe virus and Ganjam virus OTUs bound to sheep ISG15 were solved and compared to complexes of Crimean-Congo hemorrhagic fever virus and Erve virus OTUs bound to human and mouse ISG15, respectively. Through mutational and structural analysis seven residues in ISG15 were identified that predominantly influence ISG15 species specificity among nairovirus OTUs. Additionally, OTU residues were identified that influence ISG15 preference, suggesting the potential for viral OTUs to adapt to different host ISG15s. These findings provide a foundation to further develop research methods to trace nairovirus-host relationships and delineate the full impact of ISG15 diversity on nairovirus infection.

Indexed as

Amino Acid SequenceAnimalsAntigens, NeoplasmCrystallography, X-RayCytokinesHEK293 CellsHost-Pathogen InteractionsHost SpecificityHumansMiceModels, MolecularNairovirusPeptide HydrolasesPhylogenyProtein BindingProtein Interaction Domains and MotifsAntigens, NeoplasmCytokinesISG15 protein, humanovarian tumor associated antigenPeptide HydrolasesUbiquitinUbiquitinsViral Proteins

Identifiers

PMID31869347
PMCPMC6927636
OpenAlexW2997302526

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.